
Incorporated in 1992, Galaxy Medicure operates as a manufacturer, trader, and exporter of medical devices, specialising in Plaster of Paris Bandages (POP Bandage) and other surgical dressings in India. In FY25, the company derives 88.64% of revenue from private customers and 11.36% from government sales. Its core products are POP Bandage B.P. and Elastic Adhesive Bandage B.P., which contributed 57.17% and 31.85% of FY25 revenue, respectively. Galaxy Medicure holds 25 registered trademarks in India for its product brands. The company has a strong export presence across multiple countries, with Bangladesh being the largest export market, contributing ₹7.24 crore in FY25. The company has a distribution network with 81 distributors across 12 states in FY25.
Bidding starts for all investor categories
Last day to place your bid
Share allotment finalised
Refunds credited for non-allottees
Allotted shares credited to demat account
Shares list on NSE / BSE
Post-close dates are indicative as per SEBI T+3 listing framework and may change per registrar updates.
| Investor Type | Min Lots | Min Shares | Min Amount | Max Lots | Max Amount | Notes |
|---|---|---|---|---|---|---|
| Retail / Individual | 1 | 2000 | ₹108,000 | 1 | ₹108,000 | 1 lot only |
| HNI | 2 | 4000 | ₹216,000 | 2 | ₹216,000 | Min 2 lots |
| Category | Reservation | Shares Offered | Amount (₹ Cr) | Shares Bid | Subscribed | Allotment % |
|---|---|---|---|---|---|---|
| QIB | 50% | 2,095,238 | 11 | 0 | 0.00x | 100% |
| NII | 15% | 628,571 | 3.3 | 0 | 0.00x | 100% |
| Retail | 35% | 1,466,667 | 7.7 | 0 | 0.00x | 100% |
Retail is a lottery-based allotment when oversubscribed; QIB/NII get pro-rata. Probability ≈ 1 / subscription times (100% if under-subscribed).